Home › AEterna Zentaris' (AEZS) Buy Rating Reiterated at Canaccord Genuity
 

Keywords :   


AEterna Zentaris' (AEZS) Buy Rating Reiterated at Canaccord Genuity

2016-04-05 02:28:39| Biotech - Topix.net

's stock had its "buy" rating reissued by analysts at Canaccord Genuity in a research report issued on Monday, MarketBeat.Com reports. They presently have a $9.00 price target on the biopharmaceutical company's stock, down from their prior price target of $13.00.

Tags: buy rating aeterna buy rating

Category:Biotechnology and Pharmaceuticals

Latest from this category

All news
»
30.09Eastern North Pacific Tropical Weather Outlook
30.09Tropical Depression Joyce Forecast Advisory Number 11
30.09California governor blocks landmark AI safety bill
30.09Tropical Storm Isaac Graphics
30.09Tropical Storm Isaac Forecast Discussion Number 17
30.09Tropical Storm Isaac Wind Speed Probabilities Number 17
30.09Tropical Storm Isaac Forecast Advisory Number 17
30.09Tropical Storm Isaac Public Advisory Number 17
More »